Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

December 18, 2024 | Investors in People, People Management, Wellbeing, Workplace, culture 

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

Investors in People Platinum logo

Cuttsy+Cuttsy is proud to announce that it has been awarded a Platinum accreditation by Investors in People, the highest-ranking score available and a remarkable leap up from its previous gold status. Out of the 55,000 organisations worldwide that are part of the Investors in People framework, only 2% achieve this prestigious top-tier status, making this achievement even more significant. 

This accolade honours the company’s relentless dedication to outstanding people management, employee wellbeing, and its drive to set benchmarks for excellence in workplace culture. 

The Investors in People accreditation is an internationally recognised standard for people management and employee wellbeing, aimed at improving workplace culture and engagement.  

Achieving the top rating of Platinum signifies a business’s exceptional commitment to fostering a positive work environment. This improvement from gold demonstrates Cuttsy+Cuttsy’s commitment to investing in its workforce, helping to increase productivity and in fostering a healthier, more engaged team. 

Mathew Cutts, Co-Founder says, “We are an agency where people matter and nowhere is this demonstrated more clearly than in achieving Investors in People — Platinum. We were able to achieve this by demonstrating excellence in people management and an obligation to employee wellbeing which is validated through vigorous assessments and feedback from employees”.  

Harriet Karia, Managing Director adds, “Being awarded Platinum is a proud moment for us as it reflects high levels of employee satisfaction, motivation, and productivity, and is a testament to our business’s dedication to its team and the efforts of everyone involved to make Cuttsy+Cuttsy a great place to work.” 

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...

Cuttsy+Cuttsy becomes employee owned

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.